Pfizer is developing an online platform for patients to order medicine, Oliver Barnes of The Financial Times reports, citing people familiar with the matter. The website is expected to launch later this year and would connect customers in the US to telehealth consultants to prescribe the medication before a drug-dispensing partner would ship the prescription, the sources added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Genmab-Pfizer gain full FDA approval for TIVDAK in Metastatic Cervical Cancer
- Labcorp: FDA approves nAbCyte Anti-AAVRh74var HB-FE Assay
- Options Volatility and Implied Earnings Moves This Week, April 29 – May 02, 2024
- PFE Upcoming Earnings Report: What to Expect?
- Pfizer (NYSE:PFE) Notches Up on New FDA Approval